Deputy Director
University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
Hamburg, Germany
Katja Weisel, MD, is associate professor and Deputy Head the Department of Oncology, Hematology and Bone Marrow Transplantation with Dept. of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg Germany as well as Co-Director of the University Cancer Center Hamburg (UCCH). Prof Weisel received her medical degree from the Medical School of the University of Ulm, Germany, and did her clinical residency in internal medicine at the University of Tübingen, Germany. She did a postdoctoral research fellowship in the laboratory of Developmental Hematopoiesis at the Memorial Sloan-Kettering Cancer Center in New York, NY, USA. She completed her medical fellowship in internal medicine and hematology, oncology at the University of Tübingen. Since 2006, Prof Weisel has been leading the Tübingen myeloma program before she moved to Hamburg in 2019, where she is now deputy head of the hematology and oncology department and the Comprehensive Cancer Center and is leading the myeloma and lymphoma program. Her myeloma research interests focus on treatment optimisation for high-risk myeloma, renally-impaired myeloma patients and further difficult-to-treat patient groups. She is a member of the German Speaking Myeloma Multicenter Group (GMMG) steering committee. Prof Weisel is co-investigator in all GMMG trials and is the lead investigator of several investigator-initiated trials, including the GMMG-CONCEPT trial. Furthermore, she was the principle investigator in several national and international phase I-III trials. Prof Weisel has contributed to more than 250 publications on multiple myeloma treatment and biology.
Disclosure information not submitted.
Management of HR Disease: Changes in Clinical Trials in HR disease
Thursday, September 26, 2024
9:30 AM – 9:40 AM East Coast USA Time
Thursday, September 26, 2024
10:00 AM – 10:30 AM East Coast USA Time